Walleye Capital LLC Aravive, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.85 - $2.75 $68,425 - $101,714	-36,987 Closed	0 $0
Q4 2021 Mar 03, 2022	SELL	$2.19 - $4.07 $39,634 - $73,658	-18,098 Reduced 32.85%	36,987 $0
Q3 2021 Nov 15, 2021	BUY	$3.67 - $5.8 $85,092 - $134,478	23,186 Added 72.69%	55,085 $205,000
Q2 2021 Aug 16, 2021	BUY	$4.65 - $6.42 $148,330 - $204,791	31,899 New	31,899 $191,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.